HORMONAL-REGULATION OF CA125 TUMOR-MARKER EXPRESSION IN HUMAN OVARIAN-CARCINOMA CELLS - INHIBITION BY GLUCOCORTICOIDS

被引：0
|
作者：
KARLAN, BY
AMIN, W
CASPER, SE
LITTLEFIELD, BA
机构：
[1] YALE UNIV, SCH MED, DEPT OBSTET & GYNECOL, DIV GYNECOL ONCOL, NEW HAVEN, CT 06510 USA
[2] YALE UNIV, SCH MED, YALE COMPREHENS CANC CTR, NEW HAVEN, CT 06510 USA
来源：
CANCER RESEARCH | 1988年 / 48卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3502 / 3506
页数：5
相关论文
共 50 条
  • [31] EVALUATION OF THE OVARIAN-CANCER ANTIGEN, CA-125, AS A TUMOR-MARKER
    ONETTO, M
    BRUZZONE, M
    CONTE, PF
    RUVOLO, M
    CONIO, A
    CHIARA, S
    FALCONE, A
    BENTIVOGLIO, G
    SERRA, GE
    PAGANUZZI, M
    ONCOLOGY, 1989, 46 (02) : 117 - 122
  • [32] Prevalence of K-RAS mutations and CA125 tumor marker in patients with ovarian carcinoma
    Bagherlou, Nazanin
    Farajnia, Safar
    Zahri, Saber
    Tabrizi, Ali Dastranj
    Nazari, Atefeh
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2020, 11 (01) : 75 - 82
  • [33] THE PROGNOSTIC VALUE OF EARLY CA125 SERUM ASSAY IN EPITHELIAL OVARIAN-CARCINOMA
    FISKEN, J
    LEONARD, RCF
    STEWART, M
    BEATTIE, GJ
    STURGEON, C
    ASPINALL, L
    ROULSTON, JE
    BRITISH JOURNAL OF CANCER, 1993, 68 (01) : 140 - 145
  • [34] AN OVARIAN-CANCER TUMOR-MARKER, CA-125, COMES OF AGE
    BULLER, RE
    DISAIA, PJ
    WESTERN JOURNAL OF MEDICINE, 1990, 152 (04): : 406 - 407
  • [35] THE USE OF CA125 AS A TUMOR-MARKER FOR ADENOCARCINOMAS OF ENDOCERVIX, ENDOMETRIUM AND FALLOPIAN-TUBE
    SCHARL, A
    CROMBACH, G
    MUSCH, H
    VIERBUCHEN, M
    BOLTE, A
    BRITISH JOURNAL OF CANCER, 1987, 56 (04) : 520 - 520
  • [36] Regulation of CA 125 expression in cultured human carcinoma cells
    Marth, C
    Zeimet, AG
    Widschwendter, M
    Daxenbichler, G
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1998, 13 (04): : 207 - 209
  • [37] CROSS-SPECIFICITY OF THE TUMOR-MARKER CA-19-9 - A CASE OF OVARIAN-CARCINOMA WITH RECURRENT VENOUS THROMBOSIS
    SMELLIE, S
    LAMBERT, M
    ACTA GASTRO-ENTEROLOGICA BELGICA, 1987, 50 (02): : 241 - 242
  • [38] ESTRADIOL, PROGESTERONE, 17-HYDROXYPROGESTERONE, ANDROSTENEDIONE AND CA125 IN PATIENTS WITH OVARIAN-CARCINOMA
    MANESCHI, F
    GERACI, P
    BARRECA, PV
    PALISI, F
    ADRAGNA, F
    NAPOLI, M
    GYNECOLOGICAL ENDOCRINOLOGY, 1992, 6 (01) : 25 - 30
  • [39] INTRAABDOMINAL MILIARY TUBERCULOSIS PRESENTING AS DISSEMINATED OVARIAN-CARCINOMA WITH ASCITES AND RAISED CA125
    PENNA, L
    MANYONDA, I
    AMIAS, A
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1993, 100 (11): : 1051 - 1053
  • [40] MORPHOLOGIC CHARACTERISTICS, PROLIFERATION, AND TUMOR-MARKER EXPRESSION OF 2 HUMAN OVARIAN-CARCINOMA CELL-LINES IN 3-DIMENSIONAL CULTURE
    MORIMITSU, Y
    YANO, H
    KOJIRO, M
    GYNECOLOGIC ONCOLOGY, 1993, 48 (02) : 155 - 164
12345